Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
01 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/en/news-release/2024/10/01/2955788/0/en/Nxera-Pharma-Appoints-Experienced-Commercial-R-D-Executive-Makoto-Sugita-as-Chief-Medical-Officer-and-President-of-Nxera-Pharma-Japan.html
01 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/en/news-release/2024/10/01/2955787/0/en/Nxera-Pharma-Enters-New-Commercial-Partnership-with-Shionogi-for-QUVIVIQ-in-Japan.html
24 Sep 2024
// BIOSPECTRUM ASIA
https://www.biospectrumasia.com/news/25/24939/nxera-pharma-receives-approval-of-insomnia-drug-in-japan.html
23 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/24/2951862/0/en/Nxera-Pharma-Receives-Approval-of-QUVIVIQ-daridorexant-25-and-50-mg-in-Japan-for-the-Treatment-of-Insomnia.html
13 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/13/2945711/0/en/Nxera-s-Partner-Cancer-Research-UK-to-Present-on-Phase-1-2a-Clinical-Trial-with-Cancer-Immunotherapy-Drug-HTL0039732-at-ESMO.html
11 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/11/2944350/0/en/Nxera-Pharma-s-Partner-Centessa-Announces-Positive-Interim-Phase-1-Clinical-Data-with-its-Novel-Orexin-Receptor-2-OX2R-Agonist-ORX750-in-Acutely-Sleep-Deprived-Healthy-Volunteers.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?